Resmetirom: Especially tell your healthcare provid
Post# of 147661
Strong CYP2C8 inhibitors, such as gemfibrozil (concomitant use not recommended)
Moderate CYP2C8 inhibitors, such as clopidogrel (reduce dosage)
OATP1B1 and OATP1B3 inhibitors, such as cyclosporine (concomitant use not recommended)
Statins, such as atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin and simvastatin (limit the statin dosage)
CYP2C8 substrates, such as loperamide, montelukast, or paclitaxel (may increase the risk of side effects).
https://www.drugs.com/rezdiffra.html
__________
LL ---- over 20 different trials, 2k patients & not a single 1 of these warnings attached.
LL ---- A therapeutic drug that does not, cause, interaction problems for the patient / doctor.
Phenominal.
Invaluable.